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Abstract
Hepatic hydatid disease has been reported from ancient times. It is a zoonotic 
infection caused by nine recognized species of tapeworms of the genus Echinococcus. 
Some of them are known to cause human echinococcosis, and there is reasonable 
doubt regarding the others. Diagnosis is supported by epidemiological history, clin-
ical presentation, radiological imaging, and serological tests. Various pathological 
forms may become life-threatening, and in those cases, the treatment is extremely 
complex. The main objective of the treatment is to completely cure the illness in 
order to avoid further complications and recurrences. Hepatic surgery, using differ-
ent techniques, achieves best results with acceptable morbidity and mortality rates. 
In the South of Chile, the geographical location in which we work, this illness is 
endemic with high incidence and prevalence. The hepatobiliopancreatic units of the 
regional surgical centers of Temuco have plenty of experience treating liver hydatid 
disease. In this chapter we shall focus especially on epidemiology, etiopathogenesis, 
diagnosis, and surgical treatment of hepatic hydatidosis.
Keywords: hepatic hydatidosis, epidemiology, etiopathogeny, diagnosis,  
surgical treatment
1. Introduction
Human echinococcosis, also called hydatidosis, is a zoonosis which has been 
known from ancient times. There are mentions about hydatid disease both in 
humans and animals in documents as old as the Ebers Papyrus and the Babylonian 
Talmud [1, 2]. Around the mid-nineteenth century, a significant breakthrough 
happened when the etiology and the life cycles of different Echinococcus species 
were defined, although there are still many related questions pending to resolve 
[3]. Hydatid disease is caused by nine recognized species of tapeworm of the genus 
Echinococcus (E.). Seven of them cause different forms of human echinococcosis, 
and the remaining two are being studied for a possible human affectation. Some 
of the life cycles of these tapeworms have domestic animals as hosts, e.g., dogs as 
definitive hosts and sheep as intermediate hosts. Humans are accidental intermedi-
ate hosts. Other species of these parasites have wild life cycles, infecting almost 
exclusively wild animals and rarely humans. Additionally, more complex cycles 
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with interaction of wild and domestic animals have been described as well. There 
are reported variants of these cycles depending on geographical location [4].
Cystic echinococcosis, the most common form of hydatidosis, is an endemic 
zoonosis caused by the larval stage (metacestodes) of the tapeworm E. granulosus. 
In relation to the geographical distribution, the disease is present in many coun-
tries around the world [5]. The diagnosis is supported by epidemiological history, 
anamnestic data, clinical presentation, radiological imaging, and serological tests. 
Surgical treatment employs different techniques, aiming for the best outcome for 
the patient. Partial cystectomy, pericystectomy, and hepatic resection are per-
formed by either open or laparoscopic surgical access, with or without neoadjuvant 
or adjuvant medical therapy. There are also different procedures for the evacua-
tion of the parasite, using percutaneous or endoscopic access. In selected cases, 
antiparasitic drug therapy is employed as the only treatment for this illness [6]. 
The prognosis for these patients will depend on the selection of the most adequate 
therapy according to several factors mainly related to the physical status of the 
patient and the larval stage of the parasite and its location [7]. Complicated cases 
must be treated in reference centers by well-trained and experienced hepatobiliary 
surgeons. This zoonosis has not yet been completely eradicated, and if affected 
countries do not apply epidemiological control policies, a great amount of resources 
will have to be allocated to the treatment of this illness. Cystic echinococcosis of 
the liver is endemic, especially in the South of Chile [8]. For this reason, the main 
theme of this chapter will be centered in topics concerning this form of hydatidosis.
2. Epidemiology
The most common form of hydatidosis is cystic echinococcosis caused by  
E. granulosus; it is present in several countries around the world and represents a 
major public health problem in some regions [9, 10]. It is considered endemic in 
areas such as Peru, Chile, Argentina, Uruguay, southern Brazil, the Mediterranean 
region, Central Asia, Western China, and East Africa [11]. Antarctica is the only 
continent free of this parasitic disease, and it has also been eradicated through 
efficient epidemiological control programs in Iceland, New Zealand, Tasmania, 
Falkland Islands, and Cyprus [12]. This pathology affects different organs, although 
the liver is the most commonly compromised, accounting for 70–75% of the cases. 
Alveolar echinococcosis caused by E. multilocularis is restricted to the Northern 
Hemisphere and might determine high morbidity and mortality [13]. Polycystic 
echinococcosis is caused by E. vogeli and only reported in Central and South 
America with low incidence rates [14]. Unicystic echinococcosis, caused by  
E. oligarthrus, is extremely rare in humans, and the only localization in which it has 
been reported is the orbit of the eye and the myocardium [15]. Other two species of 
the genus Echinococcus, E. shiquicus [16] and E. felidis [17], are present in the Tibetan 
Plateau and Africa, respectively, and there are investigations about risks of human 
affectation. In the South of Chile, cystic echinococcosis is an endemic zoonosis with 
an average incidence of 1.9/100,000 and a mortality rate of 0.2/100,000 inhabit-
ants. The hospital discharge rate corresponds to 6.3/100,000, and this figure rises to 
28.1/100,000 in our Araucanía Region [8].
3. Etiopathogeny
Hydatidosis is caused by the larval stages of taeniid cestodes of the genus 
Echinococcus. There are nine species of this tapeworm currently identified, eight 
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well-defined species and one genotypic cluster, that in future investigations could 
be defined as one to three different species. These nine species of Echinococcus are 
as follows: E. granulosus sensu stricto, E. equinus, E. ortleppi, E. multilocularis,  
E. vogeli, E. oligarthrus, E. canadensis cluster, E. shiquicus, and E. felidis. Each of 
them has a different life cycle, transmission routes, pathology forms of clinical 
presentation, possible human affectation, different geographical location, and 
biological behavior. Some of these species may affect humans, others only animals, 
and in others this is still unclear [18]. For example, regarding E. shiquicus and  
E. felidis, although they were known to infect only animals, there is growing appre-
hension about an eventual human affectation, and there is an ongoing research to 
support this with molecular and genomic studies [19, 20]. Other species of these 
parasites have exclusively wild life cycles. The study of their complex genotypic 
diversity aims to successfully prevent the transmission of this infection to humans 
[21]. The life cycle of these parasites starts with adult taeniid cestodes living in 
the small intestine of canids or felids (definitive host). Next, the adult tapeworms 
release their eggs, thus contaminating the feces, which are then ingested by 
rodents, ungulates, other herbivores, and occasionally humans (intermediate 
hosts). When humans are infected, the eggs reach the small intestine, and larval 
oncospheres hatch, which adhere and penetrate the intestinal mucosa by using 
their hooks and then migrate through the portal circulation to reach their first 
fixed location in the liver (50–70% of the cases). This happens most commonly 
in the right hepatic lobe due to the anatomical distribution of the portal venous 
system. The lungs are affected in 20–30% of the cases and much less frequently the 
spleen, kidneys, heart, muscles, bone, and central nervous system. For example, 
once located in the liver, the metacestodes begin their development and growth 
giving place to the formation of the hydatid cyst [22].
The anatomical structure of the cyst has an outer acellular laminated membrane 
that allows the entry of nutrients from the host. Then there is the inner nucleated 
germinal membrane, in which the daughter vesicles are produced. In an asexual 
form, the protoscoleces are formed inside the daughter vesicles. The immunological 
system of the intermediate host reacts to isolate the parasite, forming a fibrous layer 
called adventitia, which can calcify with the passage of time (Figure 1A, B). The life 
cycle closes when the animal’s definitive host is fed by contaminated viscera, and 
each protoscolece can develop an adult tapeworm in its small intestine [23] capsules 
and scolices.
Figure 1. 
(a) Hepatic solitary cyst, rounded, whitish external wall of uniform thickness. The cyst contains turbid liquid 
color upon formalin fixation and whitish yellowish germinal and laminated layer floating within the cyst.  
(b) The wall of the hydatid cyst has a laminated acellular membrane and a germinal layer with brood.
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WHO-IWGE Radiologic characteristics Definition of cyst
CL Unilocular cystic lesion with uniform anechoic content, cyst wall not 
visible
Cystic lesion
CE1 Unilocular cystic lesion with uniform anechoic content, cyst wall visible, 
snowflake sign
Active cyst
CE2 Multivesicular, multiseptated cysts, daughter cysts present, honeycomb 
sign
Active cyst
CE3A Unilocular cyst containing liquid with a floating membrane inside, 
water-lily sign
Transitional cyst
CE3B Cysts with daughter cysts in solid matrix
CE4 Cysts with heterogeneous hypoechoic or hyperechoic degenerative 
contents, no daughter cysts
Inactive cyst
CE5 Cysts characterized by a thick calcified wall, which is arch shaped, 
producing a cone-shaped shadow; degree of calcification varies from 
partial to complete
Inactive cyst
Table 1. 
WHO-IWGE ultrasound classification.
4. Diagnosis
Currently, the diagnosis must always consider the epidemiological background. 
The definitive diagnosis is reached through the use of imaging and in some cases 
with the additional contribution of serology. In the near future, earlier stages of the 
parasitosis will be diagnosed by means of advances in immunological tests [24, 25].
4.1 Clinical features
Humans remain asymptomatic for a prolonged period of time after being 
infected due to the slow growth of the hydatid cyst in the liver (1–5 mm per year). 
Small and medium cysts of central hepatic location are usually asymptomatic, or a 
slight pain in the epigastrium and right hypochondrium might be reported by the 
patient, together with a sensation of abdominal discomfort. Besides, the previ-
ous immune status of the patient and the anatomical location of the cyst could 
determine a late manifestation of the first symptoms [26]. When the cysts grow 
and reach a significant size, the mass effect on the bile tree and hepatic vasculature 
determine other clinical manifestations derived from biliary obstruction, portal 
hypertension, and Budd-Chiari syndrome. The magnitude of this effect will 
determine different degrees of jaundice and portal hypertension, which may range 
from a slight increase of bilirubinemia and the appearance of venous collaterals of 
the abdominal wall to very severe jaundice, ascites, and upper digestive hemorrhage 
secondary to rupture of the gastroesophageal varices [27].
4.2 Imaging
In 1981, Gharbi reported an ultrasonography classification of the hepatic 
hydatidosis, describing five categories in relation to the morphological findings of 
the cysts, according to their stage of evolution [28]. In 2002, based on this classifica-
tion, the World Health Organization Informal Working Group on Echinococcosis 
(WHO-IWGE) formulated a new classification adding two more categories, with 
the aim of guiding in the selection of the best treatment and follow-up of the 
results obtained (Tables 1 and 2) [29–31]. Current imaging offers several tools to 
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guide a better management of this disease. Usually, the imaging diagnostic begins 
with the use of ultrasonography (US), and then other imaging tests could also be 
used to achieve a better diagnosis of the most complex forms of parasitosis, such 
as contrast-enhanced ultrasound (CEUS), computed tomography (CT), magnetic 
resonance imaging (MRI), magnetic resonance cholangiography (MRC), endo-
scopic retrograde cholangiography (ERC), and conventional X-rays.
4.2.1 Ultrasonography
The US is widely used due to its low cost and high-definition images, which 
allow to define the pathological characteristics of hepatic hydatid cysts and 
other locations in the peritoneal cavity (Figures 2–4). It is also useful for the 
differential diagnosis of hydatid cyst with other liver tumors. The use of mobile 
devices allows having a portable tool for the screening of populations in endemic 
WHO Surgery PAIR Drug 
therapy
Suggestion Resource setting
CE1 ✓ ✓ <5 cm ABZ PAIR
PAIR
>5 cm PAIR+ALB
PAIR
Optimal
Minimal
Optimal
Minimal
CE2 ✓ ✓ ✓ Other PT + ALB
Other PT
Optimal
Minimal
CE3a ✓ ✓ Other PT < 5 cm
ABZ PAIR >5cmPAIR+
ABZ
PAIR
Optimal
Minimal
Optimal
Minimal
CE3b ✓ ✓ ✓ Non-PAIR PT + ABZ
Non-PAIR PT
Optimal
Minimal
CE4 Watch and wait Optimal
CE5 Watch and wait Optimal
Table 2. 
Suggested stage-specific approach to uncomplicated cystic echinococcosis of the liver.
Figure 2. 
Cyst of solid appearance (CE4).
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Figure 3. 
Heterogeneous matrix. Ball of wool sign (CE4).
areas with high risk of affectation [30, 32, 33]. Due to the difficult differentiation 
of certain forms of alveolar echinococcosis from other kinds of hepatic tumors, 
CEUS is being increasingly used in certain regions with endemic affectation of 
this pathology [34].
4.2.2 Computed tomography
Sometimes, the ultrasound does not help much in the diagnosis of liver hyda-
tidosis for different reasons, such as obesity, presence of abundant intestinal gas, 
hydatid recurrence, or residual cavities secondary to previous surgery. When that 
is the case, CT is used, taking advantage of its higher sensitivity and specificity. 
Unenhanced CT allows to have a better radiological diagnosis of the different forms 
of cyst calcification [33]. The contrast-enhanced CT aids in choosing the best 
surgical techniques according to the different forms of presentation or complica-
tions related to the disease, e.g., by allowing a more accurate appreciation of the 
involvement of the vasculature and biliary tree. CT also aids in diagnosing the cystic 
migration to the thorax and the biliary tree [35, 36]. Another advantage of the use 
of contrast-enhanced CT is to achieve a better differential diagnosis from other 
focal liver lesions [37] (Figures 5–11A, B).
Figure 4. 
Calcified anterior wall of cyst. Arciform image (white arrow).
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4.2.3 Magnetic resonance imaging
MRI is useful for diagnosis of cases of cholangiohydatidosis. Compared to US 
and CT, the MRI T2-weighted sequence is better at defining the internal structure 
of the cyst. In general, it is indicated for patients that present difficulties when 
performing ultrasound, such as bowel gas excess, previous surgeries, disseminated 
hydatidosis, and obesity. In addition, MRI is recommended when CT is contraindi-
cated due to comorbidities. MRC is used to determine the existence of cysto-biliary 
fistula and the presence of hydatid material in the biliary tree. It also visualizes 
the cysto-biliary fistula both toward the bronchi and to the biliary tree [38, 39] 
(Figures 11a, b–17).
4.2.4 Endoscopic retrograde cholangiography
The rupture of a hydatid cyst in the intrahepatic bile duct can initiate some 
complications, which might become serious mainly due to the development of 
Figure 5. 
Unilocular cyst (CE1, white arrow). Detached membrane. Cyst (CE2, white star).
Figure 6. 
Contrast-enhanced CT. Septated cyst (white arrow).
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Figure 7. 
Daughter vesicles in mother cyst (white arrow).
Figure 8. 
Coronal contrast-enhanced CT. CE3 A, water-lily sign (white arrow).
Figure 9. 
Central matrix. Daughter vesicles. Cartwheel sign (white arrow).
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cholangitis and septicemia. In these cases, the ERC provides the diagnosis and 
performs the removal of hydatid material, with the objective of improving the 
general conditions of the patient before carrying out the definitive surgical 
treatment [40].
Figure 10. 
Dome location with annular calcification (CE 5, white arrow).
Figure 11. 
(A) US content, heterogeneous with a solid appearance (CE4). (B) In the same patient, the contrast-enhanced 
CT diagnoses an unilocular hydatid cyst (CE1).
Figure 12. 
MRI T2 axial. Detached membranes. Hypointense pericyst (white arrow). Water-lily sign.
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Figure 13. 
MRI T2 axial. Detached membranes (white star). Hydatid membranes in bile duct (white arrow).
Figure 14. 
MRI coronal. Detached membranes. Bile duct with membranes (white arrow).
Figure 15. 
MR cholangiography. Residual cyst membranes (white star). Cholangiohydatidosis.
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4.3 Serology
Currently, diagnosis and follow-up of patients with cystic echinococcosis are 
achieved especially through imaging. Serology is used for the same purpose, using 
the detection of IgG-specific antigens. However, low sensitivity and specificity rates 
have been reported. In addition, false positives appear during follow-up due to the 
persistence of antibodies over time. There is a lot of research (recombined proteins, 
isotopic antibodies, subisotopic IgG, synthetic peptides), which seek to develop 
new antibodies by means of the molecular technique, allowing a better diagnosis of 
this parasitosis [41, 42].
5. Complications
Frequently, there are complications secondary to the hepatic location of the cyst 
or by involvement of adjacent organs, in which case symptoms and signs of greater 
intensity will appear. Among them, the following should be mentioned:
• More intense pain might appear when the Glisson capsule is stressed by larger 
cysts. In these cases, an abdominal mass mobilizing together with the respira-
tory movements is visualized during the physical examination. These giant 
cysts are easily visualized with the ultrasound. CT allows to define in more 
detail the elevated right hemidiaphragm and the development of secondary 
pulmonary basal atelectasis.
• Another complication of large cysts occurs when there is an intrahepatic 
breach or rupture of the cyst to the peritoneum either spontaneously or by 
trauma. The discharge of fertile hydatid fluid in the liver or peritoneal cavity 
causes anaphylaxis of a different magnitude and new hydatid implants [43]. 
These complications are better visualized with the use of CT.
• Cyst rupture and emptying of hydatid fluid or membranes into the biliary 
tree lead to obstructive jaundice, many times accompanied by severe acute 
cholangitis [44, 45]. The cysts can become infected as well and determine the 
formation of liver abscesses, which can sometimes lead to septicemia. In these 
cases, CT and MRC allow to achieve a better definition of the characteristics 
of the abscess and whether there is emptying of hydatid material into the 
biliary tree.
• The chronic inflammatory process of hepatic cysts located in segments of the 
liver dome determines firm adhesions to the right hemidiaphragm and even 
transits toward the pleuropulmonary space. As a result of this transphrenic 
transit, patients may present pleural empyemas or bronchopneumonia [46]. 
CT and MRC help to achieve a better definition and provide the most appropri-
ate and safe management.
• There are occasions in which large cysts may be more complicated due to the 
simultaneous rupture and emptying of hydatid material to the biliary tree and 
bronchi. A bilio-pleuro-bronchial fistula is established with the occurrence of 
the pathognomonic sign of bilioptysis, i.e., the expectoration of the bile. These 
patients present a fairly severe septic episode with hepatic and respiratory 
functional compromise [47]. The thorax-abdominal CT and MRC are useful to 
diagnose this complication [39].
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• Rarely, cysts located adjacent to the retrohepatic vena cava can rupture and 
cause severe cardiorespiratory failure due to bilateral pulmonary arterial 
embolism with multiple pulmonar hydatid dissemination [48]. In that case, a 
CT angiography (CTA) is used to better diagnose this serious complication.
6. Surgical treatment
The main objective of the treatment of hepatic hydatidosis is the eradication of 
the parasite and avoidance of recurrence. There is consensus, in considering surgery 
as the best option to achieve this purpose. It is currently possible to perform dif-
ferent surgical techniques with acceptable rates of morbidity and mortality, which 
are applied according to the pathological conditions of cysts. In cases of greater 
complexity, surgery can be complemented with other therapies such as minimally 
invasive procedures and chemotherapy. Surgical treatment has indications and 
contraindications depending on the patient’s condition and the forms of disease 
presentation [6].
At the dawn of the surgery to treat hepatic hydatidosis, only conservative 
techniques were used. Among them, marsupialization consisted in the opening 
and extraction of the parasite followed by externalizing the residual cavity toward 
the abdominal wall, waiting for the closure by secondary intention. Cysto-
enteroanastomosis was also performed, anastomosing the hepatic residual cavity 
into the duodenum or a defunctionalized jejunal loop. Currently, these conserva-
tive techniques are not indicated due to the high risk of complications such as 
recurrences, liver abscesses, intestinal obstruction, biliary fistulas, biliomas, 
biliary peritonitis, cholangitis, and septicemia. However, there are surgical centers 
that report good results in cases with large cysts treated by laparoscopic cystojeju-
nostomy [49].
There are various procedures of resective surgery performed in different 
surgical centers. When indicated, it is necessary to consider age, general condition 
of the patient, pathological state of the cysts and location in other organs, and the 
existence of important comorbidities difficult to control. Despite being a benign 
pathology, its evolution can sometimes be very complicated, requiring multiple sur-
geries and leading to a poor prognosis. The surgical resections are performed either 
through open or laparoscopic surgery. The following are the most used techniques 
from least to greatest complexity.
6.1 Subtotal cystectomy by open surgery
This technique, performed by open surgery, follows the steps below according to 
the location of the cysts (Figures 18–21):
• Right or bilateral subcostal laparotomy.
• In order to obtain a good access to the cyst, the section of the round ligament 
and the dissection of adhesions to the diaphragm or adjacent organs might be 
required. The use of intraoperative ultrasound is useful in posterior and central 
cyst locations, to avoid injuring the retrohepatic cava vein or hepatic veins.
• During puncture and removal of the fluid and hydatid membrane, it is neces-
sary to isolate the surgical field with compresses embedded in scolicidal agents 
(20% hypertonic saline solution or diluted povidone iodine).
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• Wide resection of the adventitia and further revision to eliminate daughter 
vesicles in cavities located in the remaining adventitia.
• Identification and suture of biliary communications.
• Closure of the residual cavity by means of capitonnage or omentoplasty. In giant 
cysts, capitonnage is not recommended to avoid distortion of the biliary tree 
and intrahepatic vasculature with subsequent functional sequelae.
• In some cases, to prevent postoperative biliary fistulae, a drain is placed in the 
residual cavity, or a choledocostomy with a Kehr tube is performed.
• When the cyst is close to the main bile duct or to the subhepatic and cava vein, the 
adjacent adventitia should be left in situ to prevent biliary fistulae or bleedings.
Figure 16. 
MRI T2 coronal septated cysts. Multiple daughter vesicles (white star). Membranes in bile duct (white arrow).
Figure 17. 
MR cholangiography. Same findings as demonstrated in Figure 15.
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Figure 18. 
Open surgery. Multiple cysts (yellow arrow).
Figure 19. 
Hepatic mobilization. Subcostal laparotomy.
6.2 Laparoscopic subtotal cystectomy
Laparoscopic subtotal hepatic cystectomy has all the advantages of minimally 
invasive procedures (Figures 22–24). It offers magnified vision with better appre-
ciation of the cyst, residual cavity, and biliary communications. In addition, it pres-
ents less postoperative pain and earlier discharge. Comparative studies are reported 
Figure 20. 
Open surgery. Subtotal cystectomy biliary communications (yellow arrow).
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between the two techniques, and the future trend seems to prefer laparoscopic 
technique [50]. However, technical difficulties currently persist to avoid the spillage 
of fertile hydatid material into the peritoneal cavity with anaphylactic reactions and 
secondary hydatid implants. For this reason, and to prevent this complication and 
Figure 21. 
Subtotal cystectomy. Giant hydatid cyst. Retrohepatic cava vein (yellow-dotted arrow).
Figure 22. 
Laparoscopic subtotal pericystectomy. Dissection of diaphragm adhesion.
Figure 23. 
Protection of the surgical field, iodine povidone.
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a possible uncontrollable bleeding, the laparoscopic approach is contraindicated in 
the following situations:
• Cyst diameter more than 10 cm
• More than three cysts and/or presence of peritoneal cysts or in other organs
• Very thin or calcified adventitia
• Cysts located in the dome and central locations of the liver
• Complicated cysts with rupture and emptying on the biliary tree or 
peritoneum
• Imaging signs of accentuated pericystic inflammation
• Cysts with fibrous adhesions to the diaphragm on the way to a thoracic 
migration
Following the rules of laparoscopic liver surgery, the location of the entrance 
ports depends on the anatomical location of the cysts. To prevent the spillage of 
hydatid material into the peritoneal cavity, it is necessary to have a good puncture 
and aspiration system, similar to Perforator-Grinder [51].
6.3 Pericystectomy
Open or laparoscopic pericystectomy is based on the concept of complete parasite 
removal. This technique consists of resecting the cyst by a plane through the hepatic 
parenchyma adjacent to the adventitia, thus achieving avoidance of recurrence due 
to the presence of daughter vesicles in the adventitia or in the surrounding hepatic 
parenchyma [52]. In cases of complicated cysts, pericystectomy is not recommended 
due to the risk of further bleeding or bile duct injuries. Previous radiological studies 
are crucial to determine the relationship of these structures with the cysts. Currently, 
laparoscopic pericystectomy helps to prevent the aforementioned risks thanks to its 
magnified vision, more efficient hepatic transection instruments, and widespread 
access (Figure 25). Well-trained surgeons in laparoscopic hepatic surgery have a 
better chance of successfully performing this technique [53].
Figure 24. 
Partial resection of adventitia.
17
Surgical Treatment of Hepatic Hydatidosis
DOI: http://dx.doi.org/10.5772/intechopen.86319
6.4 Hepatic resection
Sometimes it is necessary to carry out liver resections, e.g., when there are hydatid 
recurrences in the same lobe previously operated or in residual cavities, which have the 
risk of subsequent infection with development of liver abscesses and cholangitis. When 
the infection is controlled by antibiotic therapy or percutaneous drainages, it is recom-
mended to resect the compromised lobe, which is usually more atrophic. This surgery 
will be consequently more laborious. Nevertheless, the compensatory hypertrophy of 
the unaffected lobe determines a lower risk of postoperative hepatic failure. With the 
aim of completely eradicating the parasite and preventing recurrence, several surgi-
cal centers perform hepatic resection more frequently by both open and laparoscopic 
surgeries with acceptable morbidity and very low mortality. Liver resection is more 
indicated in alveolar echinococcosis by higher frequency of recurrence and infiltrative 
behavior similar to malignant neoplasms. There are recent reports of liver transplanta-
tion and also ex vivo resection surgery with autotransplantation for this type of echino-
coccosis [54]. Summarizing, hepatic resection, not very used in the past, now appears as 
a viable alternative for selected cases carried out in specialized reference centers.
The morbidity of resective surgery depends on the complexity of the hydatidosis 
and the magnitude of the surgery performed. Among the most difficult to treat are 
biliary fistulas, bleeding, and infections. For example, for patients with fistulization 
of the cyst toward the bile duct and thorax, it is advisable to work in stages, e.g., 
treating cholangitis first, and then, when the patient is stabilized, a pleural empy-
ema is drained. Once general conditions have been recovered, the resective surgery 
is indicated. In relation to morbidity and mortality rates, what has been reported so 
far shows a great disparity of figures. A surgeon from our university conducted a 
Figure 25. 
Steps of laparoscopic pericystectomy.
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study of the risk factors that determine the postoperative morbidity in a significant 
number of international publications. The results indicate a fairly low level of 
evidence [55]. The challenge is to perform a prospective series, to achieve consensus 
on the indications of surgery to treat this complex disease.
7. Percutaneous treatment
This therapy is carried out by means of puncture, aspiration, injection of scolici-
dal agents, and reaspiration of fluid and hydatid membranes (PAIR). The procedure 
is performed under ultrasonographic guidance in selected cases. This procedure was 
developed by a Tunisian team in 1986. The WHO recommends this procedure 
because it is less invasive when compared to surgery, allows a good evacuation of the 
parasite, reduces the time of hospitalization, and is less expensive. The following 
guidelines contain indications and contraindications for this procedure (Tables 3 
and 4) [56]. It is necessary to have anesthesiological support to treat an eventual 
anaphylaxis crisis due to hydatid fluid spillage while PAIR is performed [57].
8. Chemotherapy
The use of treatments with drugs capable of penetrating and collapsing hepatic 
hydatid cysts is reported in numerous publications. These drugs are prescribed alone or 
together with surgery and less-invasive therapies such as PAIR. Currently, albendazole 
has shown effectiveness in reducing the size or even causing the death of the parasite. 
For this reason, it is employed to prevent recurrence after surgery. It is also used as the 
only therapy in patients who refuse surgery or who are inoperable due to disseminated 
1. Non-echoic lesion 5 cm in diameter
2. Cysts with daughter cysts and/or membrane detachment
3. Multiple cysts if accessible to puncture
4. Infected cysts
5. Patients who fail to respond to chemotherapy alone
6. Patients in whom surgery is contraindicated
7. Patient who refuse surgery
8. Patients who relapse after surgery
9. Children >3 years old
10. Pregnant women
Table 3. 
Indications for PAIR.
1. Noncooperative patient
2. Inaccessible or risky location of the liver cyst
3. Cyst in the spine, brain, and/or heart
4. Inactive or calcified lesion
5. Cyst communicating with the biliary tree
Table 4. 
Contraindications for PAIR.
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hydatidosis or because of other comorbidities [58]. In Chile, it is indicated preopera-
tively in doses of 10 mg/kg of weight for one cycle of 14 or 21 days and postoperatively 
from one to three cycles according to eventual appearance of hepatic dysfunction.
9. Conclusion
Hepatic hydatidosis is still a disease that spreads without epidemiological control 
in many parts of the world. Also, a continuous biological adaptation of the parasite 
to subsist in the intermediate host has been demonstrated, which would explain 
the great difficulties in eradicating this zoonosis. The permanent and even increas-
ing incidence of this disease determines very high health costs necessary to treat 
patients, sometimes with complex pathological presentations. Efforts are being 
made to find new alternatives to diagnose early stages of the parasitosis. The creation 
of new vaccines with the intention of immunizing the intermediate host would 
determine a better control of human hydatidosis. Surgical advances are allowing for 
more and more radical surgical procedures with acceptable rates of morbidity and 
mortality. However, the implementation of minimally invasive surgeries presents 
significantly higher costs. Logic would dictate that the best path is to minimize the 
number of new patients affected through successful epidemiological control.
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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